Lipid, lipoprotein, and apolipoprotein models: past, present, and futureZECH, L. A.Mathematical biosciences. 1984, Vol 72, Num 2, pp 407-414, issn 0025-5564Article

In vivo metabolism of apolipoprotein A-I in a patient with homozygous familial hypercholesterolemiaSCHAEFER, J. R; RADER, D. J; IKEWAKI, K et al.Arteriosclerosis and thrombosis. 1992, Vol 12, Num 7, pp 843-848, issn 1049-8834Article

Etretinate: persistent serum levels after long-term therapyDI GIOVANNA, J. J; ZECH, L. A; RUDDEL, M. E et al.Archives of dermatology (1960). 1989, Vol 125, Num 2, pp 246-251, issn 0003-987XArticle

Lipodystrophic diabetes mellitus. Investigations of lipoprotein metabolism and the effects of Omega-3 fatty acid administration in two patientsSTACPOOLE, P. W; ALIG, J; KILGOR, L. L et al.Metabolism, clinical and experimental. 1988, Vol 37, Num 10, pp 944-951, issn 0026-0495Article

The association of LDL receptor activity, LDL cholesterol level, and clinical course in homozygous familial hypercholesterolemiaSPRECHER, D. L; HOEG, J. M; SCHAEFER, E. J et al.Metabolism, clinical and experimental. 1985, Vol 34, Num 3, pp 294-299, issn 0026-0495Article

Determination of the radiation dose from administered apolipoprotein tracers in humans : In vivo tracer kinetics and modelingVENKATAKRISHNAN, V; FISHER, W. R; ZECH, L. A et al.Metabolism, clinical and experimental. 1997, Vol 46, Num 10, pp 1231-1239, issn 0026-0495Conference Paper

Easy and practical utilization of CONSAM for simulation analysis, and optimization of complex dosing regimensJACKSON, A. J; ZECH, L. A.Journal of pharmaceutical sciences. 1991, Vol 80, Num 4, pp 317-320, issn 0022-3549, 4 p.Article

Delayed low density lipoprotein (LDL) catabolism despite a functional intact LDL-apolipoprotein B particle and LDL-receptor in a subject with clinical homozygous familial hypercholesterolemiaSCHMIDT, H. H.-J; STUHRMANN, M; MANNS, M. P et al.The Journal of clinical endocrinology and metabolism. 1998, Vol 83, Num 6, pp 2167-2174, issn 0021-972XArticle

Pharmacokinetics of dacarbazine in the regional perfusion of extremities with melanomaDIDOLKAR, M. S; JACKSON, A. J; LESKO, L. J et al.Journal of surgical oncology. 1996, Vol 63, Num 3, pp 148-158, issn 0022-4790Article

ApoB metabolism in familial hypercholesterolemia : inconsistencies with the LDL receptor paradigmFISHER, W. R; ZECH, L. A; STACPOOLE, P. W et al.Arteriosclerosis and thrombosis. 1994, Vol 14, Num 4, pp 501-510, issn 1049-8834Article

Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiencyIKEWAKI, K; RADER, D. J; NAGANO, M et al.The Journal of clinical investigation. 1993, Vol 92, Num 4, pp 1650-1658, issn 0021-9738Article

Epinephrine kinetics in humans: radiotracer methodologyROSEN, S. G; LINARES, O. A; SANFIELD, J. A et al.The Journal of clinical endocrinology and metabolism. 1989, Vol 69, Num 4, pp 753-761, issn 0021-972X, 9 p.Article

In vivo metabolism of proapolipoprotein A-I in Tangier diseaseBOJANOVSKI, D; GREGG, R. E; ZECH, L. A et al.The Journal of clinical investigation. 1987, Vol 80, Num 6, pp 1742-1747, issn 0021-9738Article

Norepinephrine metabolism in humans: kinetic analysis and modelLINARES, O. A; JACQUEZ, J. A; ZECH, L. A et al.The Journal of clinical investigation. 1987, Vol 80, Num 5, pp 1332-1341, issn 0021-9738Article

Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemiaHOEG, J. M; MAHER, M. B; BREWER, H. B. JR et al.The American journal of cardiology. 1986, Vol 57, Num 11, pp 933-939, issn 0002-9149Article

Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patientsSPRECHER, D. L; SCHAEFER, E. J; KENT, K. M et al.The American journal of cardiology. 1984, Vol 54, Num 1, pp 20-30, issn 0002-9149Article

Upregulated synthesis of both apolipoprotein A-I and apolipoprotein B in familial hyperalphalipoproteinemia and hyperbetalipoproteinemiaSCHMIDT, H. H.-J; GREGG, R. E; TIETGE, U. J. F et al.Metabolism, clinical and experimental. 1998, Vol 47, Num 9, pp 1160-1166, issn 0026-0495Article

Erdheim-Chester disease : Low low-density lipoprotein levels due to rapid catabolismSCHMIDT, H. H.-J; GREGG, R. E; SHAMBUREK, R et al.Metabolism, clinical and experimental. 1997, Vol 46, Num 10, pp 1215-1219, issn 0026-0495Article

The ³H-leucine tracer : Its use in kinetic studies of plasma lipoproteinsFISHER, W. R; VENKATAKRISHNAN, V; FISHER, E. S et al.Metabolism, clinical and experimental. 1997, Vol 46, Num 3, pp 333-342, issn 0026-0495Conference Paper

Disappearance of two major phosphatidylcholines from plasma is predominantly via LCAT and hepatic lipaseSHAMBUREK, R. D; ZECH, L. A; COOPER, P. S et al.American journal of physiology. Endocrinology and metabolism. 1996, Vol 34, Num 6, pp E1073-E1082, issn 0193-1849Article

Apolipoprotein A-II production rate is a major factor regulating the distribution of apolipoprotein A-I among HDL subclasses LpA-I and LpA-I:A-II in normolipidemic humansIKEWAKI, K; ZECH, L. A; KINDT, M et al.Arteriosclerosis, thrombosis, and vascular biology. 1995, Vol 15, Num 3, pp 306-312, issn 1079-5642Article

World-wide access to computer models of biological systemsWASTNEY, M. E; BROERING, N; RAMBERG, C. F. R. JR et al.Information services & use. 1995, Vol 15, Num 3, pp 185-191, issn 0167-5265Conference Paper

In vivo metabolism of a mutant form of apolipoprotein A-I, apo A-I_Milano, associated with familial hypoalphalipoproteinemiaROMA, P; GREGG, R. E; MENG, M. S et al.The Journal of clinical investigation. 1993, Vol 91, Num 4, pp 1445-1452, issn 0021-9738Article

In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I,A-IIRADER, D. J; CASTRO, G; ZECH, L. A et al.Journal of lipid research. 1991, Vol 32, Num 11, pp 1849-1859, issn 0022-2275Article

Metabolism of immunoglobulin E in patients with markedly elevated serum immunoglobulin E levelsDRESKIN, S. C; GOLDSMITH, P. K; STROBER, W et al.The Journal of clinical investigation. 1987, Vol 79, Num 6, pp 1764-1772, issn 0021-9738Article